Sandra Rutz

640 total citations
14 papers, 324 citations indexed

About

Sandra Rutz is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Sandra Rutz has authored 14 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Psychiatry and Mental health and 4 papers in Molecular Biology. Recurrent topics in Sandra Rutz's work include Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (6 papers) and Acute Kidney Injury Research (3 papers). Sandra Rutz is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (6 papers) and Acute Kidney Injury Research (3 papers). Sandra Rutz collaborates with scholars based in Germany, Sweden and Switzerland. Sandra Rutz's co-authors include Ekaterina Manuilova, Kaj Blennow, Oskar Hansson, Henrik Zetterberg, Leslie M. Shaw, Hugo Vanderstichele, Kai‐Uwe Eckardt, Carsten Willam, Michael Weyand and Ivan Formentini and has published in prestigious journals such as PLoS ONE, Alzheimer s & Dementia and Neuroendocrinology.

In The Last Decade

Sandra Rutz

12 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Rutz Germany	9	153	118	73	70	34	14	324
E. van den Berg Netherlands	8	82 0.5×	33 0.3×	41 0.6×	31 0.4×	29 0.9×	16	252
Lihua Xia China	11	38 0.2×	46 0.4×	66 0.9×	30 0.4×	38 1.1×	30	351
Yifan Liang China	12	67 0.4×	37 0.3×	68 0.9×	30 0.4×	49 1.4×	18	339
Woo Yeong Chung South Korea	10	103 0.7×	71 0.6×	132 1.8×	30 0.4×	8 0.2×	47	417
Francesc Pujadas Spain	14	95 0.6×	74 0.6×	60 0.8×	18 0.3×	160 4.7×	31	446
Jeannette Simino United States	11	51 0.3×	71 0.6×	53 0.7×	10 0.1×	45 1.3×	21	292
Giuseppe Bellini Italy	11	71 0.5×	17 0.1×	52 0.7×	31 0.4×	37 1.1×	22	339
Rahul Bhambri United States	9	75 0.5×	132 1.1×	132 1.8×	51 0.7×	8 0.2×	22	344
Eva‐Maria Paulus Germany	10	23 0.2×	113 1.0×	31 0.4×	25 0.4×	17 0.5×	20	506
Soriul Kim South Korea	12	104 0.7×	26 0.2×	47 0.6×	43 0.6×	8 0.2×	40	365

Countries citing papers authored by Sandra Rutz

Since Specialization

Citations

This map shows the geographic impact of Sandra Rutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Rutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Rutz more than expected).

Fields of papers citing papers by Sandra Rutz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Rutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Rutz. The network helps show where Sandra Rutz may publish in the future.

Co-authorship network of co-authors of Sandra Rutz

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Rutz. A scholar is included among the top collaborators of Sandra Rutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Rutz. Sandra Rutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Schinke, Henrik, Stefanie Gaupp, Ekaterina Manuilova, et al.. (2025). Concordance between the updated Elecsys cerebrospinal fluid immunoassays and amyloid positron emission tomography for Alzheimer’s disease assessment: findings from the Apollo study. Clinical Chemistry and Laboratory Medicine (CCLM). 63(8). 1588–1598. 2 indexed citations

Manuilova, Ekaterina, et al.. (2025). Elecsys CSF AD immunoassays: Sample stability for a new pre‐analytical protocol for fresh CSF. Alzheimer s & Dementia. 21(10). e70797–e70797.

Blennow, Kaj, Erik Stomrud, Henrik Zetterberg, et al.. (2022). Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease. Clinical Chemistry and Laboratory Medicine (CCLM). 61(2). 234–244. 11 indexed citations

Hansson, Oskar, Sandra Rutz, Veronika Corradini, et al.. (2021). Establishment of updated biomarker cut‐off values for the second‐generation Elecsys β‐amyloid(1–42), pTau and tTau CSF immunoassays. Alzheimer s & Dementia. 17(S5). 1 indexed citations

Hansson, Oskar, Erik Stomrud, Henrik Zetterberg, et al.. (2020). Improved performance of Elecsys CSF Abeta measurement achieved using the simple, unified routine‐use protocol for CSF collection. Alzheimer s & Dementia. 16(S3).

Hansson, Oskar, Sandra Rutz, Henrik Zetterberg, et al.. (2020). Pre‐analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 12(1). 27 indexed citations

Shaw, Leslie M., Oskar Hansson, Ekaterina Manuilova, et al.. (2019). Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS. Clinical Biochemistry. 72. 7–14. 30 indexed citations

Andréasson, Ulf, Josef Pannee, Robert M. Umek, et al.. (2018). Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements. Clinical Chemistry and Laboratory Medicine (CCLM). 56(12). 2058–2066. 27 indexed citations

Molina, Rafael, Ling Qiu, Xiuyi Zhi, et al.. (2018). Technical and clinical performance of a new assay to detect squamous cell carcinoma antigen levels for the differential diagnosis of cervical, lung, and head and neck cancer. Tumor Biology. 40(4). 3726238820–3726238820. 13 indexed citations

10.

Hansson, Oskar, Alvydas Mikulskis, Anne M. Fagan, et al.. (2018). The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review. Alzheimer s & Dementia. 14(10). 1313–1333. 91 indexed citations

11.

Dimopoulou, Christina, Marcus Ising, Harald J. Schneider, et al.. (2016). Body Image Perception in Acromegaly Is Not Associated with Objective Acromegalic Changes but Depends on Depressive Symptoms. Neuroendocrinology. 105(2). 115–122. 13 indexed citations

12.

Schley, Gunnar, Ekaterina Manuilova, Sandra Rutz, et al.. (2015). Comparison of Plasma and Urine Biomarker Performance in Acute Kidney Injury. PLoS ONE. 10(12). e0145042–e0145042. 73 indexed citations

13.

Schley, Gunnar, et al.. (2015). Comparative analysis of diagnostic and predictive performance of novel renal biomarkers in plasma and urine of acute kidney injury patients. Intensive Care Medicine Experimental. 3(S1). 1 indexed citations

14.

Rutz, Sandra, et al.. (2013). NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction. Clinical Chemistry and Laboratory Medicine (CCLM). 52(4). 537–46. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact